[1]CurrentPatentAssignee:CSPCPHARMACEUTICALGROUPLIMITED-CN110343111,2019,ALocationinpatent:Page/Pagecolumn5-10
[2]CurrentPatentAssignee:LUOXINPHARMACEUTICALSGROUPSTOCKCOLTD-CN105884781,2016,ALocationinpatent:Paragraph0063
[3]CurrentPatentAssignee:LUOXINPHARMACEUTICALSGROUPSTOCKCOLTD-CN108997355,2018,ALocationinpatent:Paragraph0020;0021;0022;0025;0028
[4]CurrentPatentAssignee:SHANDONGUNIVERSITY-CN106146517,2016,ALocationinpatent:Paragraph0045;0051;0052;0065;0066-0070
[5]CurrentPatentAssignee:ZHEJIANGHUAHAIPHARMACEUTICALCO.,LTD.-CN114685510,2022,ALocationinpatent:Paragraph0047;0056-0058;0067-0069;0078-0079
[6]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2010/123919,2010,A2Locationinpatent:Page/Pagecolumn54-55
[7]CurrentPatentAssignee:KYUNGDONGPHARM.CO.,LTD.-KR2019/90729,2019,ALocationinpatent:Paragraph0097-0101
[8]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-WO2014/102826,2014,A1Locationinpatent:Paragraph0297
[9]CurrentPatentAssignee:MSNLABORATORIESPRIVATELIMITED;SAMSUNGELECTRONICSCO.,LTD.-US2016/122354,2016,A1Locationinpatent:Paragraph0171;0172
[10]CurrentPatentAssignee:NANTONGCHANGYOUPHARMACEUTICALTECH-CN105732641,2016,ALocationinpatent:Paragraph0020
[11]CurrentPatentAssignee:SUNPHARMACEUTICALINDUSTRIESLIMITED-WO2016/132341,2016,A1Locationinpatent:Page/Pagecolumn6;7
[12]CurrentPatentAssignee:P&RSPA-US2016/297825,2016,A1Locationinpatent:Paragraph0105-0108
[13]CurrentPatentAssignee:YANGTZERIVERPHARMACEUTICALGROUPCOLTD-CN107793418,2018,ALocationinpatent:Paragraph0083;0084;0085;0086;0089
[14]CurrentPatentAssignee:SINOBIOPHARMACEUTICALLIMITED-CN108948020,2018,ALocationinpatent:Paragraph0025;0030;0031
[15]CurrentPatentAssignee:LEADINGPHARMMEDICALTECH-CN109776547,2019,ALocationinpatent:Paragraph0045;0048-0049
[16]CurrentPatentAssignee:GUANGZHOUYIPINHONGPHARMACEUTICAL-CN110437234,2019,ALocationinpatent:Paragraph0063-0091
[17]CurrentPatentAssignee:SICHUANUNIVERSITY-CN110724146,2020,ALocationinpatent:Page/Pagecolumn8-14
[18]CurrentPatentAssignee:JIANGSUHYKMEDICALTECH-CN110668995,2020,ALocationinpatent:Paragraph0090-0093
[19]Siadati,SeyyedAmir;Soheilizad,Mehdi;Firoozpour,Loghman;Samadi,Marjan;Payab,Meghdad;Bagherpour,Saeed;Mousavi,SeyyedMehdi[JournalofChemistry,2022,vol.2022]
[1]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2013/90490,2013,A1Locationinpatent:Page/Pagecolumn8;9
[2]CurrentPatentAssignee:PFIZERINC-US2012/258976,2012,A1Locationinpatent:Page/Pagecolumn14
[3]CurrentPatentAssignee:PFIZERINC-US2013/303557,2013,A1Locationinpatent:Paragraph0099
[4]CurrentPatentAssignee:UNICELLAB-KR102209701,2021,B1Locationinpatent:Paragraph0061-0076
[1]Patent:CN108640921,2018,A.Locationinpatent:Paragraph0087;0091;0092
[1]CurrentPatentAssignee:SHANDONGKEXINGBIOPRODUCTS-CN108640921,2018,A
[2]CurrentPatentAssignee:SHANDONGKEXINGBIOPRODUCTS-CN108640921,2018,A
[3]CurrentPatentAssignee:SHANDONGKEXINGBIOPRODUCTS-CN108640921,2018,A
[1]CurrentPatentAssignee:SHANDONGKEXINGBIOPRODUCTS-CN108640921,2018,ALocationinpatent:Paragraph0099;0101
Title: Jiang JK, et al. Examining the chirality, conformation and selective kinase inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo,3-dpyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550). J Med Chem. 2008 Dec 25;51(24):8012-8.
Title: Onda M, et al. Tofacitinib suppresses antibody responses to protein therapeutics in murine hosts. J Immunol. 2014 Jul 1;193(1):48-55.
Title: LaBranche TP, et al. JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production. Arthritis Rheum. 2012 Nov;64(11):3531-42.
Title: Calama E, et al. Tofacitinib ameliorates inflammation in a rat model of airway neutrophilia induced by inhaled LPS. Pulm Pharmacol Ther. 2017 Apr;43:60-67.
